Evidence map›Paper›PMID 26144972›Full record

ArticleScientific reports2015

Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.

Aritreyee Datta, Anirban Ghosh, Cristina Airoldi, Paola Sperandeo, Kamal H Mroue, Jesús Jiménez-Barbero, Pallob Kundu, Ayyalusamy Ramamoorthy, Anirban Bhunia

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. A Synergic Potential of Antimicrobial Peptides againstMolecules (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Article
  13. Frontiers in plant science · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Sub-inhibitory Effects of Antimicrobial Peptides.Frontiers in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Aritreyee DattaDepartment of Biophysics, Bose Institute, P-1/12 CIT Scheme VII (M), Kolkata 700 054, India.
Anirban GhoshDepartment of Biophysics, Bose Institute, P-1/12 CIT Scheme VII (M), Kolkata 700 054, India.
Cristina AiroldiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, P.zza della Scienza 2, 2016 Milano, Italy.
Paola SperandeoDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, P.zza della Scienza 2, 2016 Milano, Italy.
Kamal H MroueBiophysics and Department of Chemistry, University of Michigan, 930 N. University Avenue, Ann Arbor, Michigan 48109-1055, USA.
Jesús Jiménez-Barbero1] Infectious Diseases Program, CIC bioGUNE, Parque Tecnologico de Bizkaia, Building 801A, 48160 Derio, Spain [2] IKERBASQUE, Basque Foundation for Science, 48011 Bilbao, Spain.
Pallob KunduDivision of Plant Biology, Bose Institute, P-1/12 CIT Scheme VII (M), Kolkata 700 054, India.
Ayyalusamy RamamoorthyBiophysics and Department of Chemistry, University of Michigan, 930 N. University Avenue, Ann Arbor, Michigan 48109-1055, USA.
Anirban Bhunia1] Department of Biophysics, Bose Institute, P-1/12 CIT Scheme VII (M), Kolkata 700 054, India [2] Biophysics and Department of Chemistry, University of Michigan, 930 N. University Avenue, Ann Arbor, Michigan 48109-1055, USA.
Bose Institute · INUniversity of Michigan–Ann Arbor · USUniversity of Milano-Bicocca · ITCIC bioGUNE · ES

Funding

Supplement: Investigation of Membrane-Bound Cytochromes-P450-b5 InteractionsR01GM084018 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAMAMOORTHY, AYYALUSAMY · 2009 to 2018
$3.8M
NIGMS NIH HHS R01 GM084018
6 · The paper itself

Abstract

The recent increase in multidrug resistance against bacterial infections has become a major concern to human health and global food security. Synthetic antimicrobial peptides (AMPs) have recently received substantial attention as potential alternatives to conventional antibiotics because of their potent broad-spectrum antimicrobial activity. These peptides have also been implicated in plant disease control for replacing conventional treatment methods that are polluting and hazardous to the environment and to human health. Here, we report de novo design and antimicrobial studies of VG16, a 16-residue active fragment of Dengue virus fusion peptide. Our results reveal that VG16KRKP, a non-toxic and non-hemolytic analogue of VG16, shows significant antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii. VG16KRKP is also capable of inhibiting bacterial disease progression in plants. The solution-NMR structure of VG16KRKP in lipopolysaccharide features a folded conformation with a centrally located turn-type structure stabilized by aromatic-aromatic packing interactions with extended N- and C-termini. The de novo design of VG16KRKP provides valuable insights into the development of more potent antibacterial and antiendotoxic peptides for the treatment of human and plant infections.

Indexed as

Amino Acid SequenceAnti-Infective AgentsAntimicrobial Cationic PeptidesCalorimetryCandidaCell Line, TumorCell SurvivalCell WallDengue VirusEscherichia coliHemolysisHumansLipopolysaccharidesMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsMolecular Sequence DataAnti-Infective AgentsAntimicrobial Cationic PeptidesLipopolysaccharides

Identifiers

PMID26144972
PMCPMC4491704
OpenAlexW1273596776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.